Controling Mean Arterial Pressure Using a Closed-Loop System for Vasopressor Titration
COMAP
Postoperative Hypotension Management With Computer-guided Vasopressor Titration in High-Risk Patients After Cardiac Surgery: A Randomized Controlled Trial
1 other identifier
interventional
40
1 country
1
Brief Summary
The investigators have developed an automated vasopressor controller to improve the titration of vasopressor in order to maintain mean arterial pressure (MAP) within a narrow range and have recently shown the controller was effective in both the operating room and intensive care unit. The controller has been used recently in a case series of three patients undergoing cardiac surgery and in five patients after cardiac surgery. The investigators want to compare now a manual to a closed-loop titration of vasopressor infusion in patients admitted in the Intensive Care unit after cardiac surgery
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 7, 2020
CompletedFirst Posted
Study publicly available on registry
October 14, 2020
CompletedStudy Start
First participant enrolled
November 26, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 17, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 17, 2020
CompletedDecember 22, 2020
December 1, 2020
21 days
October 7, 2020
December 19, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
incidence of postoperative hypotension
Percentage of treatment period spent with a MAP \< 65 mmHg
postoperative hour 2
Secondary Outcomes (6)
Number of vasopressor infusion rate modifications
postoperative hour 2
Amount of vasopressor
postoperative hour 2
amount of fluid
postoperative hour 2
incidence of acute kidney injury
postoperative day 7
troponin values
postoperative day 0
- +1 more secondary outcomes
Study Arms (2)
Manual control of vasopressor infusion
ACTIVE COMPARATORVasopressor will be manually titrated by intensive care unit nurses in charge of the patients to maintain mean arterial pressure \> 65 mmHg. Fluid administration consists in optimization of stroke volume (assisted fluid management) during the postoperative period
Computer guided vasopressor infusion
EXPERIMENTALVasopressor will be titrated automatically by the closed-loop system to maintain mean arterial pressure \> 65 mmHg. Fluid administration consists in optimization of stroke volume (assisted fluid management) during the postoperative period
Interventions
automated titration of vasopressor infusion to maintain a mean arterial pressure \> 65mmHg
manual adjustments of noradrenaline infusion
Eligibility Criteria
You may qualify if:
- Adult patient
- Elective cardiac surgery
- French speaking patient
You may not qualify if:
- Uncontrolled hypertension
- Renal insufficiency (estimated glomerular filtration rate \< 30mL/min/1,73m²)
- Left ejection fraction \< 40%
- Emergency surgery
- Preoperative infection
- Preoperative cardiac arrythmia
- Pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Clinique de la Sauvegardelead
- Bicetre Hospitalcollaborator
- Erasme University Hospitalcollaborator
Study Sites (1)
Clinique de la Sauvegarde
Lyon, 69009, France
Related Publications (1)
Desebbe O, Rinehart J, Van der Linden P, Cannesson M, Delannoy B, Vigneron M, Curtil A, Hautin E, Vincent JL, Duranteau J, Joosten A. Control of Postoperative Hypotension Using a Closed-Loop System for Norepinephrine Infusion in Patients After Cardiac Surgery: A Randomized Trial. Anesth Analg. 2022 May 1;134(5):964-973. doi: 10.1213/ANE.0000000000005888.
PMID: 35061635DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Olivier Desebbe, MD
Clinique de la Sauvegarde
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 7, 2020
First Posted
October 14, 2020
Study Start
November 26, 2020
Primary Completion
December 17, 2020
Study Completion
December 17, 2020
Last Updated
December 22, 2020
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share